CYP3A43

From WikiMD's WELLNESSPEDIA

CYP3A43[edit]

CYP3A43 is a member of the cytochrome P450 superfamily of enzymes. These enzymes are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. The CYP3A43 gene is located on chromosome 7q22.1 and is part of a cluster of cytochrome P450 genes.

Function[edit]

CYP3A43 is involved in the metabolism of various endogenous and exogenous compounds. It is known to metabolize some drugs and is involved in the oxidative metabolism of steroids. The enzyme's activity can vary significantly between individuals due to genetic polymorphisms, which can affect drug efficacy and toxicity.

Genetic Polymorphisms[edit]

Genetic polymorphisms in the CYP3A43 gene can lead to variations in enzyme activity. These polymorphisms can influence an individual's response to certain medications, making pharmacogenomics an important consideration in personalized medicine. Some polymorphisms have been associated with altered drug metabolism, which can impact the effectiveness and safety of therapeutic drugs.

Clinical Significance[edit]

Variations in CYP3A43 activity can have significant clinical implications. For example, altered enzyme activity can affect the metabolism of drugs used in the treatment of cancer, cardiovascular diseases, and other conditions. Understanding these variations can help in optimizing drug dosages and reducing adverse drug reactions.

Related Cytochrome P450 Enzymes[edit]

CYP3A43 is closely related to other members of the CYP3A subfamily, including CYP3A4, CYP3A5, and CYP3A7. These enzymes share similar substrate specificities and are involved in the metabolism of a wide range of drugs and endogenous compounds.

Research and Future Directions[edit]

Ongoing research is focused on understanding the full range of substrates metabolized by CYP3A43 and the impact of genetic polymorphisms on its activity. This research is crucial for the development of personalized medicine approaches that take into account individual genetic differences in drug metabolism.

See Also[edit]

References[edit]

External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.